Milestone Pharmaceuticals Inc. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b80fd667-0609-413e-8473-23d0d3075dd6/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-62.1M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-032415 |
| FY 2024 | $-42.1M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-002849 |
| FY 2023 | $-61.1M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-003666 |
| FY 2022 | $-59.6M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004871 |
| FY 2021 | $-43.1M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004205 |
| FY 2020 | $-50.7M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-003631 |
| FY 2019 | $-57.9M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002106 |
| FY 2018 | $-23.8M | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-002106 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).